SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-16-059543
Filing Date
2016-03-30
Accepted
2016-03-30 16:50:15
Documents
17
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 ONCOCYTE CORPORATION 10-K 12-31-2015 form10k.htm 10-K 1127465
2 EXHIBIT 10.21 ex10_21.htm EX-10.21 234608
3 EXHIBIT 10.22 ex10_22.htm EX-10.22 9707
4 EXHIBIT 23.1 ex23_1.htm EX-23.1 2061
5 EXHIBIT 31 ex31.htm EX-31 12742
6 EXHIBIT 32 ex32.htm EX-32 4918
7 image0.jpg GRAPHIC 98772
8 image1.jpg GRAPHIC 224162
9 image2.jpg GRAPHIC 100767
10 image3.jpg GRAPHIC 27166
11 image4.jpg GRAPHIC 272943
12 image5.jpg GRAPHIC 68408
13 image6.jpg GRAPHIC 53010
14 image7.jpg GRAPHIC 37016
15 image9.jpg GRAPHIC 20255
16 image10.jpg GRAPHIC 24693
17 image00011.jpg GRAPHIC 43940
  Complete submission text file 0001140361-16-059543.txt   2729993
Mailing Address 1301 HARBOR BAY PARKWAY SUITE 100 ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY SUITE 100 ALAMEDA CA 94502 510-521-3390
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37648 | Film No.: 161540360
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences